Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey.

Environ Health Perspect · 2010 · PMC2866686 · PMID 20089479

Europe PMC DOI

hedged sentences

0.0730

closest p · 1.5× alpha

0.0730

boldest claim

The sentences

narrowly missed significancep = 0.073so close (0.05 < p ≤ 0.1)

In men, we found a similar suggestive trend, but it narrowly missed significance: Comparing PFOA concentrations ≥ 7.3 ng/mL (Q4) versus ≤ 5.2 ng/mL (Q1 and Q2), the OR for treated disease was 2.12 (95% CI, 0.93–4.82; p = 0.073).

also in 112 other papers

a decreasing trendno p-value reported

EPA 2006 ), have contributed to a decreasing trend in human exposure for all perfluorinated compounds (with the notable exception of perfluorononanoic acid) ( Calafat et al. 2007 ; Olsen et al. 2007 ).

also in 47,180 other papers

nominally significantno p-value reported

In addition, we found a nominally significant association between PFOS concentrations and treated thyroid disease in men but not in women.

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.